Geneyx Genomex
AI-based Genetic Data Analysis Platform
StartupGeneyx Genomex is a Herzliya-based startup in the Health Tech & Life Sciences sector, established in 2018. AI-based Genetic Data Analysis Platform. The company has raised a total of $14M across 8 funding rounds, currently at the Seed stage. Geneyx Genomex was founded by David Yizhar, Raviv Itzhaky, Ofer Barnea. Key investors include DigiLife, Accenture Ventures, Capri Ventures, among 4 total investors. The company has 11-50 employees. Core technologies: Platforms & Interfaces, Software, Artificial Intelligence, Biologicals, Genes.
With $14M in total funding, Geneyx Genomex is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released.
- StageSeed
- ProductReleased
- ModelB2B
- Employees11-50
- HQHerzliya
- DistrictCenter District
- Last Round$150K
- DigiLifeLead
- Accenture VenturesLead
- Capri Ventures
4 investors total
David YizharCo-founder & CEORaviv ItzhakyCo-founder & CMO
Ofer BarneaCo-founder & Scientific Advisor
10 articles covered by sources including www.calcalistech.com,
finance.yahoo.com,
www.businesswire.com,
gulfnews.com,
www.geektime.com.
What does Geneyx Genomex do?
Geneyx is driven by the belief that comprehensive genomic insights are essential for every patient’s care. Its mission is to transform the integration of genomics into healthcare and pharmaceutical research with a sophisticated data analysis platform. Serving a wide range of clients, including hospitals, genetics labs, and life-science companies, Geneyx offers unmatched precision in genetic analysis and research. Geneyx Analysis is a comprehensive platform for secondary and tertiary analysis of germline and somatic sequencing data interpretation. This comprehensive tool tailors to all aspects of in-house bioinformatic pipelines but alleviates the complexities of staying current with current genomic information. Its team strives to provide a resource that significantly improves diagnostic yields and turnaround times, and its mission is to provide a platform that achieves a world without undiagnosed diseases.
How much funding has Geneyx Genomex raised?
Geneyx Genomex has raised $14M in total funding across 8 rounds. The company is currently at the Seed stage. Key investors include DigiLife, Accenture Ventures, Capri Ventures.
Who founded Geneyx Genomex?
Geneyx Genomex was founded in 2018 by David Yizhar (Co-founder & CEO), Raviv Itzhaky (Co-founder & CMO), Ofer Barnea (Co-founder & Scientific Advisor).
What sector is Geneyx Genomex in?
Geneyx Genomex operates in Health Tech & Life Sciences, Digital Healthcare, Digital Medical Diagnostics, Medical Decision Support, with core technologies in Platforms & Interfaces, Software, Artificial Intelligence, Biologicals, Genes. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories, Providers, Life Sciences, Pharmaceuticals.
Where is Geneyx Genomex located?
Geneyx Genomex is based in Galgalei ha-Plada St 11, Herzliya, Israel, Center District. The company also has offices abroad.